Advancing care through clinical science and digital expertise.
Melbourne Digital Therapeutics brings together expertise in clinical care, neuroscience, therapy development, and digital technology.
Our team translates clinical and scientific knowledge into therapies that are practical, accessible, and designed for real-world care.
Our Team
Adam Vogel, PhD
Professor Adam Vogel is the founder and Lead of Melbourne Digital Therapeutics and Professor of Speech Neuroscience at the University of Melbourne.
Adam is a clinician-scientist whose work focuses on developing and evaluating new approaches to assessment and treatment for people living with neurological conditions. His research spans speech neuroscience, digital health and clinical trials, with more than 250 scientific publications and extensive international collaborations across academia, healthcare and industry.
His clinical and research work led to the development of SpeechATTAX, the first digital therapeutic within the MDTx platform. He founded Melbourne Digital Therapeutics to take this model further: translating evidence-based therapies into accessible digital interventions across a growing range of health domains.
LEAD CLINICAL SCIENTIST
Lucas Raniolo
Lucas Raniolo leads the development and delivery of SpeechATTAX, working across clinical research, product development and implementation.
Lucas is a speech pathologist and PhD candidate in Speech Neuroscience at the University of Melbourne, with qualifications in speech pathology and psychology. His research focuses on speech and communication in neurological conditions and the translation of clinical evidence into practical therapeutic approaches.
At MDTx, Lucas works with clinicians, researchers, people with lived experience and the product team to translate SpeechATTAX from clinical research into an accessible digital therapy for real-world use.
SPEECHATTAX PRODUCT LEAD